HUP0500509A2 - Micronized pharmaceutical or nutraceutical powder with immediate release - Google Patents

Micronized pharmaceutical or nutraceutical powder with immediate release

Info

Publication number
HUP0500509A2
HUP0500509A2 HU0500509A HUP0500509A HUP0500509A2 HU P0500509 A2 HUP0500509 A2 HU P0500509A2 HU 0500509 A HU0500509 A HU 0500509A HU P0500509 A HUP0500509 A HU P0500509A HU P0500509 A2 HUP0500509 A2 HU P0500509A2
Authority
HU
Hungary
Prior art keywords
immediate release
micronized pharmaceutical
nutraceutical powder
powder
micronized
Prior art date
Application number
HU0500509A
Other languages
Hungarian (hu)
Inventor
Jérome Besse
Laurence Besse
Original Assignee
Besins International Belgique
Galenix Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins International Belgique, Galenix Innovations filed Critical Besins International Belgique
Publication of HUP0500509A2 publication Critical patent/HUP0500509A2/en
Publication of HUP0500509A3 publication Critical patent/HUP0500509A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Abstract

A találmány tárgyát azonnali felszabadulást biztosító, mikronizáltgyógyászati vagy gyógytáppor képezi, amely azonnali felszabadulástbiztosít, részecskeméret-eloszlása 100 mm-nél nem nagyobb, és legalábbegy aktív adalékanyag, legalább egy nedvesítő szer és legalább egyhígítószer kombinációját tartalmazza.The subject of the invention is an immediate-release, micronized medicinal or herbal nutritional powder, which ensures immediate release, has a particle size distribution no larger than 100 mm, and contains a combination of at least one active additive, at least one wetting agent and at least one diluent.

HU0500509A 2001-12-27 2002-12-27 Micronized pharmaceutical or nutraceutical powder with immediate release HUP0500509A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116934A FR2834212B1 (en) 2001-12-27 2001-12-27 USE OF IMMEDIATE RELEASE POWDER IN PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
PCT/FR2002/004575 WO2003055464A1 (en) 2001-12-27 2002-12-27 Micronized pharmaceutical or nutraceutical powder with immediate release

Publications (2)

Publication Number Publication Date
HUP0500509A2 true HUP0500509A2 (en) 2005-09-28
HUP0500509A3 HUP0500509A3 (en) 2012-07-30

Family

ID=8871027

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500509A HUP0500509A3 (en) 2001-12-27 2002-12-27 Micronized pharmaceutical or nutraceutical powder with immediate release

Country Status (14)

Country Link
US (2) US20030124191A1 (en)
EP (1) EP1458356A1 (en)
JP (1) JP2005520799A (en)
AU (1) AU2002364489A1 (en)
BR (1) BR0215380A (en)
CA (1) CA2471903A1 (en)
FR (1) FR2834212B1 (en)
HU (1) HUP0500509A3 (en)
IL (1) IL162671A0 (en)
MX (1) MXPA04006181A (en)
NO (1) NO20043172L (en)
PL (1) PL370202A1 (en)
RU (1) RU2302232C2 (en)
WO (1) WO2003055464A1 (en)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
NZ518447A (en) 1999-10-29 2004-10-29 Orion Corp Treatment or prevention of hypotension and shock
RU2002120498A (en) * 1999-12-28 2004-04-10 Адзиномото Ко., Инк. (Jp) ANTI-DIABETIC DRUG FOR ORAL ADMINISTRATION
SE521512C2 (en) 2001-06-25 2003-11-11 Niconovum Ab Device for administering a substance to the front of an individual's oral cavity
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
DK1803444T3 (en) 2002-12-20 2019-02-25 Niconovum Ab PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC)
WO2004073729A1 (en) 2003-02-21 2004-09-02 Translational Research Ltd. Compositions for nasal administration of drug
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JP2005097221A (en) * 2003-09-26 2005-04-14 Sato Pharmaceutical Co Ltd Nasal drop
US8987322B2 (en) * 2003-11-04 2015-03-24 Circ Pharma Research And Development Limited Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
EP1547592A1 (en) * 2003-12-23 2005-06-29 Schwarz Pharma Ag Intranasal formulation of rotigotine
ATE498395T1 (en) * 2003-12-31 2011-03-15 Cima Labs Inc GENERAL LINEAR EFFORTABLE FORM OF FENTANYL FOR ORAL USE AND METHOD OF ADMINISTRATION
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US9114069B2 (en) 2004-08-25 2015-08-25 Aegis Therapeutics, Llc Antibacterial compositions for drug administration
US8835413B2 (en) 2004-10-20 2014-09-16 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
DE102005042875A1 (en) * 2004-12-23 2006-09-21 Grünenthal GmbH Fast-release dosage forms for antibiotics
US20060281775A1 (en) 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
MX2008009177A (en) * 2006-01-20 2008-12-05 Pear Tree Pharmaceuticals Inc Method of treating atrophic vaginitis.
EP1998748B1 (en) 2006-03-16 2015-01-14 NicoNovum AB Improved snuff composition
BRPI0709410A2 (en) * 2006-03-20 2011-07-12 Javelin Pharmaceuticals Inc pharmaceutical composition and method for treating a mammal in need of an analgesic, anti-inflammatory or antipyretic agent
AU2007230716B2 (en) * 2006-03-28 2012-05-03 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
JP5193196B2 (en) * 2006-06-02 2013-05-08 ペア ツリー ウーマンズ ヘルス ケア Methods of treatment for atrophic vaginitis
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
ES2543907T3 (en) * 2006-09-13 2015-08-25 22Nd Century Limited, Llc Increased levels of nicotinic alkaloids
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
WO2008078730A1 (en) * 2006-12-26 2008-07-03 Translational Research, Ltd. Preparation for transnasal application
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
KR20100020459A (en) * 2007-06-08 2010-02-22 아드레넥스 파마슈티컬스, 아이엔씨. Extended release formulation and method of treating adrenergic dysregulation
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
BRPI0818317A8 (en) * 2007-10-10 2018-12-18 Mallinckrodt Baker Inc composition, methods of manufacture of excipient, pharmaceutical tablet and method of manufacture thereof
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
AU2008337435A1 (en) * 2007-12-17 2009-06-25 Krka, Tovarna Zdravil, D.D., Novo Mesto Suspension comprising non-micronized ezetimibe micro-particles
US20090246273A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Ketorolac Sublingual Spray for the Treatment of Pain
US20090258865A1 (en) 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US20100022471A1 (en) * 2008-07-23 2010-01-28 Sage Products Inc. Oral Moisturizer for Alleviating Dry Mouth
RU2457857C2 (en) * 2008-08-05 2012-08-10 Виктор Владимирович Чалов Antiviral and antimicrobial composition
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
CN106511273A (en) * 2009-05-15 2017-03-22 瑞克欧制药有限公司 Sublingual dexmeditomidine compositions and methods of use thereof
WO2010131486A1 (en) 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
CN102770125B (en) * 2009-12-22 2015-02-11 利奥制药有限公司 Calcipotriol monohydrate nanocrystals
TW201309346A (en) 2011-01-05 2013-03-01 Hospira Inc Spray drying vancomycin
CN107737100A (en) 2011-06-14 2018-02-27 哈尔生物药投资有限责任公司 The administration of Benzodiazepine composition
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
WO2013090278A2 (en) 2011-12-11 2013-06-20 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN104043104B (en) 2013-03-15 2018-07-10 浙江创新生物有限公司 The spray dried powder and its industrialized process for preparing of hydrochloric vancomycin
EP3049059B1 (en) * 2013-09-24 2021-11-03 Satsuma Pharmaceuticals, Inc. Intranasal dhe formulation for the treatment of headache
US8785426B1 (en) 2013-12-13 2014-07-22 Upsher-Smith Laboratories, Inc. Testosterone gel compositions and related methods
CN104042562A (en) * 2014-05-21 2014-09-17 丽珠医药集团股份有限公司 Novel solid preparation of roxithromycin
KR20170005819A (en) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 Natural combination hormone replacement formulations and therapies
KR101729236B1 (en) * 2015-06-01 2017-04-21 (주)노터스생명과학 TLR7 agonist agent for treatment and prevention of liver disease
CN108156807A (en) * 2015-06-30 2018-06-12 韩美药品株式会社 Medicine compound preparation containing Amlodipine, Losartan and Rosuvastatin
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
PL3500255T3 (en) 2016-08-19 2023-03-13 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
CA3045043A1 (en) 2016-12-31 2018-07-05 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
KR20200118034A (en) 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 Intranasal delivery of olanzapine by a precision olfactory organ device
US10792246B2 (en) 2018-06-27 2020-10-06 Bioxcel Therapeutics, Inc. Film formulations containing dexmedetomidine and methods of producing them
CN109125733A (en) * 2018-10-30 2019-01-04 成都先手生物科技有限公司 A kind of composition for the treatment of of arthritis and its application
WO2020123607A1 (en) 2018-12-11 2020-06-18 Satsuma Pharmaceuticals, Inc. Compositions, devices, and methods for treating or preventing headaches
KR20220049526A (en) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 Non-sedative dexmedetomidine treatment regimen
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
MX2022014216A (en) 2020-05-18 2022-12-07 Orexo Ab New pharmaceutical composition for drug delivery.
AR127780A1 (en) 2021-11-25 2024-02-28 Orexo Ab NEW PHARMACEUTICAL COMPOSITION THAT COMPRISES ADRENALINE
CN115501236B (en) * 2022-11-09 2024-01-23 复旦大学附属肿瘤医院 Application of enogestrel acetate in preparation of medicines for reducing lung inflammatory diseases
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
JPH01213245A (en) * 1988-02-20 1989-08-28 Ueno Seiyaku Oyo Kenkyusho:Kk Production of solid sorbitol
DE3827362A1 (en) * 1988-08-12 1990-02-15 Basf Ag POWDERY, HYDROPHILE THEOPHYLINE FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
US5157030A (en) * 1989-08-25 1992-10-20 Alexander Galat Rapidly soluble aspirin compositions and method
US5320848A (en) * 1991-05-28 1994-06-14 Affinity Biotech, Inc. Chewable drug-delivery composition
FR2758459B1 (en) * 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
WO1999024019A1 (en) * 1997-11-06 1999-05-20 Orbon Corporation Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
UA72207C2 (en) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Pharmaceutical formulations of efavirenz and disintegrants providing for increasing dissolution rate and process of manufacturing such tablets or capsules
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2795962B1 (en) * 1999-07-08 2003-05-09 Prographarm Laboratoires PROCESS FOR THE MANUFACTURE OF MASK TASTE COATED GRANULES AND IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
US6978894B2 (en) * 1999-12-20 2005-12-27 Merck & Co., Inc. Blister package for pharmaceutical treatment card

Also Published As

Publication number Publication date
JP2005520799A (en) 2005-07-14
FR2834212B1 (en) 2004-07-09
HUP0500509A3 (en) 2012-07-30
BR0215380A (en) 2004-12-07
RU2004122919A (en) 2005-04-10
FR2834212A1 (en) 2003-07-04
NO20043172L (en) 2004-09-14
IL162671A0 (en) 2005-11-20
MXPA04006181A (en) 2005-04-19
RU2302232C2 (en) 2007-07-10
PL370202A1 (en) 2005-05-16
AU2002364489A1 (en) 2003-07-15
EP1458356A1 (en) 2004-09-22
CA2471903A1 (en) 2003-07-10
WO2003055464A1 (en) 2003-07-10
US20030124191A1 (en) 2003-07-03
US20050118272A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
HUP0500509A2 (en) Micronized pharmaceutical or nutraceutical powder with immediate release
MXPA04004791A (en) Micronized film-forming powder comprising an active substance.
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
HUP0203556A2 (en) Pharmaceutical compositions containing oxcarbazepine and their use
EP1476138A4 (en) Modified release formulations of at least one form of tramadol
EP1240915A3 (en) Wire having a definied location of frangibility
SG117445A1 (en) Flash-melt oral dosage formulation
ITMI20011337A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT
HUP0102206A2 (en) Delavirdine tablet formulation
BR9908815A (en) Inhalation device
BRPI0408655A (en) formulations comprising an active agent and cocoa powder and their use
EP1757269A3 (en) Pulmonary formulation comprising silicon particles
DE60209929D1 (en) SUCCINATE OF 5,8,14-TRIAZATETRACYCLOÄ10.3.1.0 2,11 .0 4,9 Ü-HEXADECA-2 (11), 3,5,7,9, -PENTAES AND PHARMACEUTICAL COMPOSITIONS
MY127350A (en) Flash-melt oral dose formulations
AP2004003046A0 (en) Dosage regimen and pharmaceutical composition for emergency contraception.
TW200733954A (en) Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
WO2003035686A3 (en) Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
WO2005065639A3 (en) Novel pharmaceutical compositions
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
DE60202590D1 (en) 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
WO2002069979A3 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
WO2005030142A8 (en) Rifalazil formulations
IL159006A0 (en) Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same
DE60311665D1 (en) PHARMACEUTICAL COMPOSITIONS
EP1443932A4 (en) Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees